UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended ~~August~~February 3128, ~~2024~~2025

☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ____________ to ____________

Commission File Number: 333-194055

AMJ Global Technology

(Exact name of registrant as specified in its charter)

Nevada

33-1230169

(State or other jurisdiction

of incorporation)

(IRS Employer

Identification Number)

2470 E Flamingo Rd., Suite A

Las Vegas, NV 89121

(Address of principal executive offices)

(213) 709-4296

(Registrant’s telephone number, including area code)

______________________________________________

(Former name or former address, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act: None.

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ☐ Yes ☒ No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). ☒ Yes ☐ No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated Filer	☒	Smaller reporting company	☒
		Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ☐ Yes ☒ No

As of ~~October~~May 228, ~~2024~~2025, the Company had ~~107~~106,~~782~~472,~~190~~857 shares of common stock outstanding.

AMJ Global Technology

INDEX

		Page
PART I. FINANCIAL INFORMATION

Item 1.	Financial Statements	3
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	4
Item 3.	Quantitative and Qualitative Disclosures about Market Risks	8
Item 4.	Controls and Procedures	8

PART II. OTHER INFORMATION

Item 1.	Legal Proceedings	9
Item 1A.	Risk Factors	9
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	9
Item 3.	Defaults Upon Senior Securities	9
Item 4.	Mine Safety Disclosures	9
Item 5.	Other Information	9
Item 6.	Exhibits	10

SIGNATURES		11

Table of Contents

PART I – FINANCIAL INFORMATION

Item 1. Financial Statements

AMJ Global Technology

Table of Contents

		Page
Condensed Balance Sheets at August 31, 2024 and November 30, 2023 (unaudited)		F-1
Condensed Balance Sheets at February 28, 2025 and November 30, 2024 (unaudited)		F-1
Condensed Statements of Operations for the three and nine months ended August 31, 2024, and 2023 (unaudited)		F-2
Condensed Statements of Operations for the three months ended February 28,2025, and February 29,2024 (unaudited)		F-2
Condensed Statements of Changes in Stockholders’ Equity (Deficit) for the three and nine months ended August 31, 2024, and 2023 (unaudited)		F-3
Condensed Statements of Changes in Stockholders’ Deficit for the three months ended February 28, 2025, and February 29,2024 (unaudited)		F-3
Condensed Statements of Cash Flows for the nine months ended August 31, 2024, and 2023 (unaudited)		F-5
Condensed Statements of Cash Flows for the three months ended February 28,2025, and February 29, 2024 (unaudited)		F-4
Notes to Unaudited Condensed Financial Statements		F-65

Table of Contents

AMJ Global Technology

Condensed Balance Sheets

(Unaudited)

	August 31,			November 30,
	February 28,			November 30,
	2024			2023
	2025			2024
ASSETS
Current Assets
Cash	$	~~229~~77		$	-226
Accounts receivable - related party		8			-
Prepaid expenses		280			5,280
Prepaid expenses		3,614			9,140
Total Current Assets		357			5,506
Total Current Assets		3,851			9,140
Equity investment -related party		886,419			376
Software and technology assets		3,371			-
Software and technology asset, net		3,023			3,371
Medicare contracts asset		337			-
TOTAL ASSETS	$	889,799		$	9,253
TOTAL ASSETS	$	7,559		$	9,140
LIABILITIES AND STOCKHOLDERS' DEFICIT
Current Liabilities
Accounts payable	$	3,393		$	750
Accounts payable and accrued liabilities	$	6,869		$	4,762
Accrued management fees - related party		~~150~~210,000			~~110~~180,000
Due to related party		7,628			16,465
Advances from related party-current portion		26,346			16,166
Total Current Liabilities		~~161~~243,~~021~~215			~~127~~200,~~215~~928
Non-current liability
Loan payable to related party, net debt discount of $109,379		890,621			-
Total Liabilities		1,133,836			200,928
Stockholders' Deficit
Common stock, $0.001 par value, 750,000,000 shares authorized, 107,782,190 and 103,033,323 shares issued and outstanding, respectively		107,782			103,033
Common stock, $0.001 par value, 750,000,000 shares authorized, 107,785,190 and 107,782,190 shares issued and outstanding, respectively		107,785			107,782
Additional paid-in capital		~~176~~179,~~817~~814			~~169~~176,~~469~~817
Accumulated deficit		(~~438~~531,~~061~~636	)		(~~390~~476,~~577~~274	)
Total Stockholders' Deficit		(~~153~~244,~~462~~037	)		(~~118~~191,~~075~~675	)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	$	7889,~~559~~799		$	9,~~140~~253

The accompanying notes are an integral part of these unaudited condensed financial statements.

F-1

Table of Contents

AMJ Global Technology

Condensed Statements of Operations

(Unaudited)

	Three Months Ended						~~Nine Months Ended~~
	August 31,						August 31,
	February 28,			February 29,
	2024			2023			2024			2023
	2025			2024
Revenues -related party	$	8		$	-		$	8		$	-
Revenues	$	-		$	-
Operating Expenses
General and administrative		71,~~120~~545			-1,500			~~10,120~~			~~1,800~~
Professional fees		718,~~949~~940			1418,~~550~~174			~~37,622~~			~~36,323~~
Management compensation		3530,~~764~~000			-30,000			~~97,859~~			~~752,380~~
Total operating expenses		50,~~833~~485			1449,~~550~~674			~~145,601~~			~~790,503~~
Operating loss		(50,~~825~~485	)		(1449,~~550~~674	)		~~(145,593~~	)		~~(790,503~~	)
Other income
Other income (expense)
Gain on settlement of debt - related party		-			-			98,109			-
Equity investment income -related party		197			-
Total other income		-			-			98,109			-
Interest expense		(4,726	)		-
Net loss before income taxes		(50,825	)		(14,550	)		(47,484	)		(790,503	)
Amortization expense		(348	)		-
Provision for income taxes		-			-			-			-
Total other expenses		(4,877	)		-
Net Loss	$	(50,825	)	$	(14,550	)	$	(47,484	)	$	(790,503	)
Net loss before income taxes		(55,362	)		(49,674	)
Basic and diluted loss per common share	$	(0.00	)	$	(0.00	)	$	(0.00	)	$	(0.01	)
Provision for income taxes		-			-
Basic and diluted weighted average common shares outstanding		104,843,639			90,523,323			103,823,750			90,199,323
Net Loss	$	(55,362	)	$	(49,674	)
Basic and diluted loss per common share	$	(0.00	)	$	(0.00	)
Basic and diluted weighted average common shares outstanding		107,782,322			103,033,323

Prior period has been restated, see Note 1 Basis of Presentation – Restatement of Previously Issued Financial Statements.

The accompanying notes are an integral part of these unaudited condensed financial statements.

F-2

Table of Contents

AMJ Global Technology

Condensed ~~Statement~~Statements of Changes in Stockholders’ Deficit

(Unaudited)

For the Three ~~and Nine~~ Months Ended ~~August~~February 3128, ~~2024~~2025

					Additional					Total
	Common Stock				Paid in		Accumulated			Stockholders'
	Shares		Amount		Capital		Deficit			Deficit
Balance - November 30, 2023		103,033,323	$	103,033	$	169,469	$	(390,577	)	$	(118,075	)
Balance - November 30, 2024		107,782,190	$	107,782	$	176,817	$	(476,274	)	$	(191,675	)
Net loss for the period		-		-		-		(49,674	)		(49,674	)
Common stock issued in cash		3,000		3		2,997		-			3,000
Balance - February 29, 2024		103,033,323		103,033		169,469		(440,251	)		(167,749	)
Net loss for the period		-		-		-		(55,362	)		(55,362	)
Common stock issued for settlement of debt- related party		202,200		203		327		-			530
Balance - February 28, 2025		107,785,190	$	107,785	$	179,814	$	(531,636	)	$	(244,037	)
Common stock issued for compensation - related party		400,000		400		648		-			1,048
Common stock issued for services - related party		400,000		400		648		-			1,048
Net income for the period		-		-		-		53,015			53,015
Balance - May 31, 2024		104,035,523		104,036		171,092		(387,236	)		(112,108	)
Common stock issued for software and development acquisition		1,333,333		1,333		2,038		-			3,371
Common stock issued for revenue sharing agreement -related party		133,334		133		204		-			337
Common stock issued for compensation - related party		2,250,000		2,250		3,437					5,687
Common stock issued for services - related party		30,000		30		46		-			76
Net loss for the period		-		-		-		(50,825	)		(50,825	)
Balance - August 31, 2024		107,782,190		107,782		176,817		(438,061	)		(153,462	)

~~F-3~~For ~~Table~~the ofThree ~~Contents~~Months Ended February 29, 2024

For the Three and Nine Months Ended August 31, 2023

					Additional					Total
	Common Stock				Paid in		Accumulated			Stockholders'
	Shares		Amount		Capital		Deficit			Deficit

Balance - November 30, 2023		103,033,323	$	103,033	$	169,469	$	(390,577	)	$	(118,075	)

Net loss for the period		-		-		-		(49,674	)		(49,674	)
Balance - February 29, 2024		103,033,323	$	103,033	$	169,469	$	(440,251	)	$	(167,749	)

					Additional					Total
	Common Stock				Paid in		Accumulated			Stockholders'
	Shares		Amount		Capital		Deficit			Deficit
Balance - November 30, 2022		89,623,323	$	89,623	$	147,412	$	(253,788	)	$	(16,753	)
Net loss for the period		-		-		-		(17,655	)		(17,655	)
Balance - February 28, 2023		89,623,323		89,623		147,412		(271,443	)		(34,408	)
Common stock issued for services - related party		900,000		900		1,480		-			2,380
Net loss for the period		-		-		-		(758,298	)		(758,298	)
Balance - May 31, 2023		90,523,323		90,523		148,892		(1,029,741	)		(790,326	)
Net loss for the period		-		-		-		(14,550	)		(14,550	)
Balance - August 31, 2023		90,523,323	$	90,523	$	148,892	$	(1,044,291	)	$	(804,876	)

Prior period has been restated, see Note 1 Basis of Presentation – Restatement of Previously Issued Financial Statements.

The accompanying notes are an integral part of these unaudited condensed financial statements.

F-43 Table of Contents

AMJ Global Technology

Condensed Statements of Cash Flows

(Unaudited)

	Nine Months Ended
	Three Months Ended
	August 31,
	February 28,			February 29,
	2024			2023
	2025			2024
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$	(4755,~~484~~362	)	$	(~~790~~49,~~503~~674	)
Adjustments to reconcile net loss to net cash used in operating activities:
Management compensation		7,859			2,380
Imputed interest		4,726			-
Gain on settlement of debt - related party		(98,109	)
Amortization expenses		348			-
Equity investments income-related party		(197	)		-
Changes in operating assets and liabilities:
Accounts receivable - related party		(8	)		-
Prepaid expenses		5,000			(8,000	)
Prepaid expenses		5,526			-
Accounts payable and accrued liabilities		2,107			(576	)
Accounts payable		2,643			3,470
Accrued management fee - related party		30,000			30,000
Accrued expenses - related party		-			750,000
Net cash used in operating activities		(13,378	)		(28,250	)
Accrued management fee - related party		90,000			-
CASH FLOWS FROM INVESTING ACTIVITIES
Net cash used in operating activities		(39,573	)		(34,653	)
Distribution from equity investments -related party		49			-
Net cash provided by Investing Activities		49			-
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from related party		39,802			34,653
Proceeds from advances from related party		10,483			28,250
Net cash provided by financing activities		39,802			34,653
Repayment of advances to related party		(303	)		-
Net change in cash for the period		229			-
Contribution from common stock issued		3,000			-
Cash at beginning of period		-			-
Net cash provided by financing activities		13,180			28,250
Cash at end of period	$	229		$	-
Net change in cash for the period		(149	)		-
Cash at beginning of period		226			-
Cash at end of period	$	77		$	-
SUPPLEMENTAL CASH FLOW INFORMATION:
Cash paid for income taxes	$	-		$	-
Cash paid for interest	$	-		$	-
NON-CASH INVESTING AND FINANCING ACTIVITIES
Common stock issued for settlement of debt - related party	$	530		$	-
Acquisition equity investment -related party	$	1,000,000		$	-
Common stock issued for compensation - related party	$	6,735		$	-
Recognition debt discount for acquisition equity investment	$	114,105		$	-
Common stock issued for services - related party	$	1,124		$	2,380
Common stock issued for software and development acquisition	$	3,371		$
Common stock issued for revenue sharing agreement - related party	$	337		$

Prior period has been restated, see Note 1 Basis of Presentation – Restatement of Previously Issued Financial Statements

The accompanying notes are an integral part of these unaudited condensed financial statements.

F-54 Table of Contents

AMJ Global Technology

Notes to Unaudited Condensed Financial Statements

~~August~~February 3128, ~~2024~~2025

NOTE 1 – ORGANIZATION, BUSINESS AND LIQUIDITY

Business

AMJ Global Technology (the ‘“Company’”) was incorporated under the laws of the State of Nevada on August 16, 2013, originally incorporated as Kange Corp. Effective April 22, 2023, the Company filed with the State of Nevada a Certificate of Amendment to its Articles of Incorporation, changing the name of the Company to AMJ Global Technology. We are a start-up company developing mobile software products, starting in Estonia and Europe, which is our initial intended market. During year 2017, we began focusing on the intersection of technology and wholistic technology-based health treatments. We retained an advisor having substantial experience in the technology sector, and two former professional athletes to advise us regarding sports health issues and treatments. We intend to provide services to formulate a treatment model to meet the needs of professional athletes that suffer from PTSD and the early onset of dementia and Alzheimer’s. The Company is currently evaluating operations in the wholistic health industry, revenue sharing generated from Medicare enrollees, life and annuity insurance sales, and having 8% right and interest on software, certain additional and related assets belonged to a technology company specializing in the development of an advanced database called ElephantSqlDB® designed to leverage AI and quantum computing performance through a specialized architecture and algorithm called the Grover’s Algorithm. The ElephantSqlDB® database is unique in that is a single database that performs multiple database functions such as supporting 11 SQL dialects in addition to artificial intelligence (AI) data storage, SQL and NoSQL queries. The object of technology assets is to target and cut cloud infrastructure costs significantly while providing immutable security in-order to combat evolving threats such as ransomware attacks .

On April 26, 2023, the Company entered into an assignment agreement with AMJ Global Entertainment, LLC, a Nevada limited liability company controlled by the Company’s CEO and director., pursuant to which AMJ Global Entertainment, LLC assigned to the Company 25% of the ownership rights to AMJ Global Entertainment’s intellectual property in connection with the “Blabeey” platform, including software, code and trade secrets at zero cost.

Basis of Presentation

The accompanying unaudited interim financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Regulation S-X. Accordingly, the financial statements are condensed and do not include all of the information and footnotes required by GAAP for complete financial statements.

In the opinion of management, all adjustments consisting of normal recurring entries necessary for a fair statement of the periods presented for: (a) the financial position; (b) the results of operations; and (c) cash flows, have been made in order to make the financial statements presented not misleading. The results of operations for such interim periods are not necessarily indicative of operations for a full year. The accompanying unaudited interim financial statements should be read in conjunction with the financial statements and related notes included in the Company’s Annual Report on Form 10-K, for the year ended November 30, ~~2023~~2024, as filed with the SEC on March 123, ~~2024~~2025.

Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. The estimates and judgments will also affect the reported amounts for certain expenses during the reporting period. Actual results could differ from these good faith estimates and judgments.

F-5

Table of Contents

Accounts Receivable

Accounts receivables are recorded in accordance with Financial Accounting Standards Board Accounting Standards Codification (ASC) 310, “Receivables.” Accounts receivables are recorded at the invoiced amount or agreement and do not bear interest. The Company does not currently have any amount recorded as an allowance for doubtful accounts. Based on the management’s estimate and based on all accounts being current, the Company has not deemed it necessary to reserve for doubtful accounts at this time.

F-6 Table of Contents

Revenue Recognition

The Company recognizes revenue from its contracts with customers in accordance with ASC 606 – Revenue from Contracts with Customers. The Company recognizes revenues when satisfying the performance obligation of the associated contract that reflects the consideration expected to be received based on the terms of the contract.

Revenue related to contracts with customers is evaluated utilizing the following steps:

	(i)	Identify the contract, or contracts, with a customer;
	(ii)	Identify the performance obligations in the contract;
	(iii)	Determine the transaction price;
	(iv)	Allocate the transaction price to the performance obligations in the contract;
	(v)	Recognize revenue when the Company satisfies a performance obligation.

The Company has one Medicare revenue sharing contract with a related party that requires 5% net generated from two Medicare contract (Note 4). During the three months ended February 28,2025, the Company acquired 25% equity stake in a company controlled by a related party for 25% net revenue generated from two Medicare contracts (Note 3). The Company recognizes the monthly revenue ~~at the beginning of August 2024~~ with thirty (30) days term of payment.

Financial Instruments and Fair Value Measurements

As defined in ASC 820” Fair Value Measurements,” fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price). The Company utilizes market data or assumptions that market participants would use in pricing the asset or liability, including assumptions about risk and the risks inherent in the inputs to the valuation technique. These inputs can be readily observable, market corroborated, or generally unobservable. The Company classifies fair value balances based on the observability of those inputs. ASC 820 establishes a fair value hierarchy that prioritizes the inputs used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurement), other inputs that are directly or indirectly observable in the market place (level 2 measurement)and the lowest priority to unobservable inputs (level 3 measurement).

The following table summarizes fair value measurements by level as of February 28,2025 and November 30,2024, measured at fair value on a recurring basis:

February 28, 2025	(Level 1)		(Level 2)		(Level 3)		Total
Assets:
Equity Investment	$	-	$	-	$	886,419	$	886,419
Liabilities
None	$	-	$	-	$	-	$	-

November 30, 2024	(Level 1)		(Level 2)		(Level 3)		Total
Assets:
Equity investment	$	-	$	-	$	376	$	376
Liabilities
None	$	-	$	-	$	-	$	-

F-6

Table of Contents

Equity Investment – Related Party

Equity investments with readily determinable fair values are measured at fair value. Equity investments without readily determinable fair values are measured using the equity method or measured at cost with adjustments for observable changes in price or impairments (referred to as the measurement alternative). We perform a qualitative assessment on a periodic basis and recognize an impairment if there are sufficient indicators that the fair value of the investment is less than carrying value. Changes in value are recorded in other income (expenses). The Company recognized the net loss (income) generated from equity investment based on investee net loss (income) by using equity method accounting.

The Equity investment in AMJ Global Entertainment, LLC (“AMJ”), a related party controlled by the Company’s CEO and director, is accounted for under the equity method as the investment provides us with the ability to exercise significant influence over operating and financial policies of AMJ. On acquisition of AMJ, the investment had no value and as of August 31, 2024, AMJ has sustained losses. The carrying amount of this investment as of August 31, 2024, is $0.

	(i)	The 25% Equity Investment in AMJ Global Entertainment, LLC (“AMJ”) acquired on April 26,2023, a related party controlled by the Company’s CEO and director, is accounted for under the equity method as the investment provides us with the ability to exercise significant influence over operating and financial policies of AMJ. On acquisition of AMJ, the investment had no value and as of February 28, 2025, AMJ has sustained losses. The carrying amount of this investment as of February 28, 2025, is $0.

	(ii)	The Equity Investments for 30% equity stake in a company controlled by a related party (“Target”) acquired on July 13,2024 and January 24,2025, is accounted for under the equity method as the investment provides the Company with the ability to exercise significant influence over operating and financial policies of Target. The carrying amount of this investment as of February 28, 2025, is $886,419.

Intangible Assets.

Intangible assets with ~~an indefinite life are not amortized and are tested for impairment annually or more frequently if events or changes in circumstances indicate that they might be impaired. Intangible assets with~~ finite lives are initially recorded at cost and amortized on a straight-line basis over the estimated economic useful lives of the respective assets. Acquired intangible assets from business combinations and asset acquisitions are recognized and measured at fair value at the time of acquisition. Those assets represent assets with finite lives and are further amortized on a straight-line basis over the estimated economic useful lives of the respective assets.

During the three months ended February 28, 2025, the Company recognized amortization expenses of $348.

Net Loss Per Share of Common Stock

The Company has adopted ASC Topic 260, “Earnings per Share” which requires presentation of basic earnings per share on the face of the statements of operations for all entities with complex capital structures and requires a reconciliation of the numerator and denominator of the basic earnings per share computation. In the accompanying financial statements, basic loss per share is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the year. Diluted earnings per share is computed by dividing net income by the weighted average number of shares of common stock and potentially dilutive outstanding shares of common stock during the period to reflect the potential dilution that could occur from common shares issuable through contingent share arrangements, stock options and warrants unless the result would be antidilutive. There ~~were~~are no ~~potentially~~ dilutive ~~shares~~or ofpotentially ~~common~~dilutive ~~stock~~securities outstanding ~~for~~during the ~~nine~~periods ~~months ended August 31, 2024 and 2023~~presented.

F-7 Table of Contents

Cash and Cash Equivalents

For purposes of balance sheet presentation and reporting of cash flows, the Company considers all unrestricted demand deposits, money market funds and highly liquid debt instruments with an original maturity of less than 90 days to be cash and cash equivalents. The Company did not have any cash equivalents at ~~August~~February 3128, ~~2024~~2025 and November 30, ~~2023~~2024. The Company had cash of $~~229~~77 and $0226 at ~~August~~February 3128, ~~2024~~2025 and November 30, ~~2023~~2024, respectively.

~~Restatement~~F-7 Table of ~~Previously Issued Financial Statements~~Contents

~~The~~Recent ~~Company~~Accounting has restated amounts reported in previously issued financial statements for the periods presented in this Quarterly Report on Form 10-Q relating to errors. The restated amounts relate to share values utilized to settle transactions with related parties.Pronouncements

The ~~following~~Company ~~tables~~has ~~present~~implemented ~~the~~all ~~restatement~~new topronouncements ~~the~~that ~~line~~are ~~items~~in ofeffect ~~our~~and ~~previously~~that ~~issued~~may impact its consolidated financial statements toand ~~reflect~~does ~~the~~not ~~correction~~believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its consolidated financial statements or results of ~~errors:~~operations.

~~Statements~~Income ~~of Operations:~~Taxes

August 31, 2023	As Reported			Adjustment			As Revised
Management compensation	$	1,650,000		$	(897,620	)	$	752,380
Net loss	$	(1,688,123	)	$	897,620		$	(790,503	)

Deferred tax assets and liabilities are recognized for the expected future tax consequences of events that have been included in the consolidated financial statements or tax returns. Under this method, deferred tax assets and liabilities are determined based on the differences between the financial reporting and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. The deferred tax assets of the Company relate primarily to operating loss carryforwards for federal income tax purposes. A full valuation allowance for deferred tax assets has been provided because the Company believes it is not more likely than not that the deferred tax asset will be realized. Realization of deferred tax assets is dependent on the Company generating sufficient taxable income in future periods.

~~Statements~~The Company periodically evaluates its tax positions to determine whether it is more likely than not that such positions would be sustained upon examination by a tax authority for all open tax years, as defined by the statute of ~~Cash~~limitations, ~~Flows:~~based on their technical merits. As of February 28, 2025, and November 30,2024, the Company has not established a liability for uncertain tax positions.

August 31, 2023	As Reported			Adjustment			As Revised
Net Loss	$	(1,688,123	)	$	897,620		$	(790,503	)
Adjustments to reconcile net loss to net cash used in operating activities:
Management compensation	$	900,000		$	(897,620	)	$	2,380

Reclassification

~~Statements~~Certain ofamounts ~~Changes~~from inprior ~~Stockholder's~~periods ~~Deficit:~~have been reclassified to conform to the current period presentation.

August 31, 2023	As Reported			Adjustment			As Revised
Additional paid -in-capital	$	4,154,207		$	(4,005,315	)	$	148,892
Accumulated deficit	$	(5,049,606	)	$	4,005,315		$	(1,044,291	)

NOTE 2 – GOING CONCERN AND LIQUIDITY CONSIDERATION

Going Concern

The accompanying condensed financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company used cash in operating activities of $3913,~~573~~378 for the ~~nine~~three months ended ~~August~~February 3128, ~~2024~~2025. The Company had an accumulated deficit of $~~438~~531,~~061~~636 at ~~August~~February 3128, ~~2024~~2025. These factors raise substantial doubt about the ability of the Company to continue as a going concern for a reasonable period of time. The Company’s continuation as a going concern is dependent upon its ability to generate revenues and its ability to continue receiving investment capital and loans from related parties to sustain its current level of operations. The Company is in the process of securing working capital from investors for common stock, convertible notes payable, and/or strategic partnerships. No assurance can be given that the Company will be successful in these efforts.

The condensed financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

NOTE 3 – EQUITY INVESTMENT - RELATED PARTY

On July 13, 2024, the Company entered into a Revenue Sharing agreement with a company controlled by a Target, a related party for acquisition of 5% of Target’s issued and outstanding stock, pursuant to which the Company will receive 5% of net revenue generated from two contracts with (i) ESS in connection with Medicare enrollees, and (ii) The Agency of North Georgia in connection with Medicare, life and annuity insurance sales in exchange for 133,334 shares of common stock for a unlimited period. The Company issued 133,334 shares of common stock issued on July 10, 2024, valued at $337. During the three months ended February 28 ,2025, the Company recognized $47 equity investment income in connection with 5% net revenue generated from two contracts.

F-8

Table of Contents

~~NOTE~~On 3January –24, ~~INTANGIBLE~~2025, the ~~ASSETS~~Company entered into a binding Letter of Intent (LOI) with AMJ Global Entertainment, LLC (“Seller”), controlled by the Company’s CEO and director for acquisition 100% of AMJ Global Entertainment’s 25% of target’s equity stake in a company controlled by a Target, a related party for amount of $1,000,000 in cash with payment term of two years with an extension of four months to pay the unpaid balance. Should the Company not be able to pay the outstanding balance at the end of twenty- eight (28) months, the Seller has agreed to take any outstanding unpaid balance in restricted stock of the Company at the price at of the stock at the time of signing agreement, which would be $1.00 per share. The Company recognized discount on non-interest-bearing loan issued by using Applicable Federal Rate (AFR) of 5.20% during the current period for amount of $114,105 and recognized the asset at fair value. During the three months ended February 28, 2025, the Company recognized $150 equity investment revenue in connection with 25% net revenue generated from Target’s contracts

The Company accounts for the equity investment under the equity method as the investment provides us with the ability to exercise significant influence over operating and financial policies of Target. As of ~~August~~February 3128, ~~2024~~2025, the Company had ~~intangible~~equity ~~assets~~investments as follows:

	August 31,
	2024
Software and technology assets	$	3,371
Medicare contracts asset		337
	$	3,708

On July 13, 2024, the Company entered into a Revenue Sharing agreement with a company controlled by a related party, pursuant to which the Company will receive 5% of net revenue generated from two contracts with (i) ESS in connection with Medicare enrollees, and (ii) The Agency of North Georgia in connection with Medicare, life and annuity insurance sales in exchange for 133,334 shares of common stock for a unlimited period. The Company issued 133,334 shares of common stock issued on July 10, 2024, valued at $337.

	As of February 28, 2025
	Acquisition #1		Acquisition #2			Total
Acquisition amount	$	337	$	1,000,000		$	1,000,337
Adjustments:
Discount on non-interest -bearing loan for acquisition		-		(114,105	)		(114,105	)
Equity investment income net of distributions received		37		150			187
	$	374	$	886,045		$	886,419

~~For~~NOTE ~~the~~4 ~~period~~– ofSOFTWARE ~~July~~AND ~~13,~~TECHNOLOGY ~~2024 (inception) to August 31, 2024, the Company recognized $8 revenue in connection with 5% net revenue generated from two contracts.~~ ASSET

OnAs ~~August~~of 25February 28, ~~2024~~2025, ~~the Company entered into a Software Purchase~~ and ~~Development~~November ~~agreement~~30, ~~pursuant~~2024, ~~to which~~ the Company ~~acquired~~had ~~an 8% interest in database~~ software and ~~related~~ technology ~~assets~~asset inas ~~exchange for 1,333,333 shares of common stock. The Company issued 1,333,333 shares of common stock on August 26, 2024, valued at $3,371.~~ follows:

NOTE 4 – RELATED PARTY TRANSACTIONS

	February 28,			November 30,
	2025			2024
Software and technology assets	$	3,371		$	3,371
Accumulated amortization		(348	)		-
	$	3,023		$	3,371

On August 25, 2024, the Company entered into a Software Purchase and Development agreement, pursuant to which the Company acquired an 8% interest in database software and related technology assets in exchange for 1,333,333 shares of common stock. The Company issued 1,333,333 shares of common stock on August 26, 2024, valued at $3,371. This asset represent asset with finite lives 5 years and are further amortized on a straight-line basis over the estimated economic useful lives of the respective assets. During the three months ended February 28, 2025, the Company recognized amortization expenses of $348. The Company did not earn revenue for three months ended February 28, 2025.

On May 7, 2025, the Company entered into a unwinding agreement with the owner of software and technology assets to terminate agreement dated August 25, 2024 (see Note 4 above). Upon the termination of the original agreement, neither party shall have any further obligations or liabilities under the original agreement, except as expressly provided in the unwinding agreement. The Company received irrevocable cancellation 1,333,333 shares of common stock on May 7, 2025 which were transferred back to the Company as treasury stock.

NOTE 5 – RELATED PARTY TRANSACTIONS

In support of the Company’s efforts and cash requirements, it may rely on advances from related parties until such a time that the Company can support its operations or attain adequate financing through sales of its equity or traditional debt financing. There is no formal written commitment for continued support by shareholders. Amounts represent advances or amounts paid in satisfaction of liabilities. The advances are non-interest bearing, considered temporary in nature, and have not been formalized by a promissory note.

On April 26, 2023, the Company entered into an assignment agreement with AMJ Global Entertainment, LLC, a Nevada limited liability company controlled by the Company’s CEO and director, pursuant to which AMJ Global Entertainment assigned to the Company 25% of the ownership rights to AMJ Global Entertainment’s intellectual property in connection with the “Blabeey” platform, including software, code and trade secrets at zero cost.

During the nine months ended August 31, 2024, and 2023, AMJ Global Entertainment LLC, a related party controlled by the Company’s CEO and director advanced to the Company an amount of $39,302 and $34,653 by paying for operating expenses on behalf of the Company and $500 and $0 in cash, respectively.

During the nine months ended August 31, 2024, and 2023, the Company recognized management fees of $90,000 and $0, respectively.

During the nine months ended August 31, 2024 and 2023, the Company issued 430,000 and 900,000 shares of common stock to advisory board members, the shares were valued and recognized compensation of $1,124 and $2,380, respectively.

During the nine months ended August 31, 2024, the Company issued 2,650,000 shares of common stock to the Company’s CEO and director and four board of directors’ members, the shares were valued and recognized compensation of $6,735.

During the nine months ended August 31, 2024, the Company’s board of directors approved the issuance of 100,000 shares of common stock for settlement of $50,000 management fees payable to the Company’s CEO and director. The shares were valued at $262, resulting in a gain of settlement on debt of $49,738.

During the nine months ended August 31, 2024, the Company’s board of directors approved the issuance of 102,200 shares of common stock for settlement of $48,639 due to AMJ Global Entertainment, LLC, a related party controlled by the Company’s CEO. The shares were valued at $268, resulting in a gain of settlement on debt of $48,371.

F-9

Table of Contents

During the ~~nine~~three months ended ~~August~~February 3128, 2025, and February 29, 2024, AMJ Global Entertainment LLC, a related party controlled by the Company’s ~~recognized~~CEO and ~~paid~~director advanced to the Company an amount of $410,~~500 office~~483 ~~rent~~and $28,250 by paying for operating expenses toon abehalf ~~company~~of ~~controlled~~the byCompany and the Company repaid advances to a related party of $303 and $0, respectively.

OnDuring ~~July 13, 2024,~~ the ~~Company~~three ~~entered~~months ~~into~~ended aFebruary ~~Revenue Sharing agreement with a company controlled by a related party~~28, ~~pursuant to which the Company acquired 5% net revenue generated from two contracts of Medicare enrollees~~2025, ~~life~~ and ~~annuity~~February ~~insurance~~29, ~~in exchange for 133,334 shares of common stock, valued at $33. For the period of July 13,~~2024 ~~(inception) to August 31~~, ~~2024,~~ the Company recognized ~~review~~management ~~sharing~~compensation of $830,000.

AtDuring ~~August~~the 31three months ended February 28, ~~2024~~2025 and ~~November~~February 3029, ~~2023~~2024, the Company ~~owed~~recognized ~~$7,628~~office ~~and~~rent expenses of $161,~~465,~~500 ~~respectively,~~and tohas ~~AMJ~~a ~~Global~~rent ~~Entertainment~~payable ~~LLC,~~of a$3000 ~~related~~at ~~party~~February ~~controlled~~28, by2025 ~~the~~and ~~Company’s~~prepaid ~~CEO~~balance ~~and~~of ~~director.~~$3,000 ~~The~~as ~~amount~~of isFebruary ~~unsecured~~29, ~~non-interest~~2024 ~~bearing~~to ~~and~~a ~~due~~company oncontrolled ~~demand~~by a related party.

~~NOTE~~On July 13, 2024, the Company acquired 5% –equity ~~COMMON~~and ~~STOCK~~revenue sharing agreement in a related party company (see Note 3 above).

On January 24, 2025, the Company acquired from AMJ Global Entertainment LLC , a related party, its 25% equity interest in another company controlled by a related party (see Note 3 above)

As of February 28, 2025, and November 30, 2024, the Company owed $26,346 and $16,166, respectively, to AMJ Global Entertainment LLC, a related party controlled by the Company’s CEO and director, respectively. The amount is unsecured, non-interest bearing and due on demand.

As of February 28, 2025, the Company owned $1,000,000 to AMJ Global Entertainment LLC, a related party controlled by the Company’s CEO and director with payment term of twenty-eight (28) months. The amount is secured with restricted 1,000,000 shares of common stock.The Company recognized discount on non-interest-bearing loan issued by using Applicable Federal Rate (AFR) of 5.20% during the current period for amount of $114,105. During the three months ended February 28, 2025, the Company recognized amortization debt discount of $ 4,726.

NOTE 6 – COMMON STOCK

Common Stock

The Company has authorized common shares of 750,000,000, par value $0.001 per share. Each outstanding share of common stock entitles the holder to one vote per share on all matters submitted to a stockholder vote. All shares of common stock are non-assessable and non-cumulative, with no pre-emptive rights.

During the ~~nine~~three months ended ~~August~~February 3128, ~~2023~~2025, the Company issued ~~following~~3,000 shares: of common stock for contribution of $3,000 in cash.

·There ~~900~~were 107,~~000~~785,190 and 107,782,190 shares of common stock toissued ~~the~~and ~~Company’s~~outstanding ~~board~~as ~~advisories~~of February 28, ~~valued~~2025, atand $2November 30,~~380~~ 2024, respectively.

~~During~~NOTE ~~the~~7 ~~nine~~– ~~months~~COMMITMENTS ~~ended~~AND ~~August 31, 2024, the Company issued following shares:~~CONTINGENCIES

·On 2January 27,~~000~~ 2025,~~000~~ ~~shares~~the ofCompany ~~common~~entered ~~stock~~into toa ~~the~~share ~~Company’s~~exchange ~~CEO~~agreement ~~and~~with ~~director,~~an ~~valued~~entity atfor $selling 5,~~056. · 650~~000,000 shares of common restricted stock tofor ~~the Company’s board of directors, valued at~~ $1~~,679~~.00 ·per ~~430~~share with 2,000,000 shares of common stock toof ~~the~~Diamond ~~Company’s~~Lake ~~advisory board members~~Mineral, ~~valued~~Inc. ata ~~$1,124.~~public ·company ~~100,000~~under ~~shares~~laws of ~~common stock against management fees payable to~~ the ~~Company’s~~state ~~CEO~~of ~~and~~Utah ~~director,~~for ~~valued at~~ $~~262~~2.50 ·per ~~102,200~~share. ~~shares~~As of ~~common~~February ~~stock~~28, ~~against amounts owed to AMJ Global Entertainment LLC~~2025, ~~a related party controlled by~~ the ~~Company’s~~transactions ~~CEO~~have ~~and~~not ~~director,~~been ~~valued at $268~~completed. ·On ~~133,334~~May ~~shares of common stock issued for Medicare contracts asset~~7, ~~valued at $337 · 1~~2025,~~333,333~~ ~~shares~~both ofparties ~~common~~agreed ~~stock~~to ~~issued~~unwind ~~for~~and ~~software~~terminate ~~and~~the ~~development~~original ~~acquisition,~~agreement ~~valued~~dated atJanuary $327,~~371~~ 2025.

There were 107,782,190 and 103,033,323 shares of common stock issued and outstanding as of August 31, 2024, and November 30, 2023, respectively.

NOTE 6 – CONCENTRATION

As of August 31, 2024, and for the nine months ended August 31, 2024, customer and revenue concentrations (more than 10%) were 100% related to one revenue sharing agreement with a related party.

NOTE 7 – SUBSEQUENT EVENTS

The Company has evaluated events occurring subsequent to the balance sheet date through the date these unaudited condensed financial statements were issued and determined there are no additional events requiring disclosure.

F-10

Table of Contents

NOTE 8 – SUBSEQUENT EVENTS

On March 17, 2025, the Company entered into a subscription agreement of 3,000 shares of common restricted stock at price of $1.00 per share. In March 2025, the Company received $3,000 contribution and 3,000 shares of common restricted stock were issued on March 18, 2025.

On March 8, 2025, the Company entered into a advisory board member agreement with compensation of 20,000 shares of common restricted stock. The advisory board member shall be entitled to an additional 20,000 shares of common restricted stock on the one-year anniversary of the signing the agreement. The Company issued 20,000 shares of common restricted stock on March 18, 2025.

On March 17, 2025, one of the Company’s stockholder returned 2,000 shares of common stock to the Company’s Treasury.

F-11

Table of Contents

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of Rule 175 of the Securities Act of 1933, as amended, and Rule 3b-6 of the Securities Act of 1934, as amended, that involve substantial risks and uncertainties. These forward-looking statements are not historical facts, but rather are based on current expectations, estimates and projections about our industry, our beliefs and our assumptions. Words such as “anticipate,” “expects,” “intends,” “plans,” “believes,” “seeks” and “estimates” and variations of these words and similar expressions are intended to identify forward-looking statements. These statements are not guarantees of future performance and are subject to risks, uncertainties and other factors, some of which are beyond our control and difficult to predict and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements. You should not place undue reliance on these forward-looking statements, which apply only as of the date of this Form 10-Q. Investors should carefully consider all of such risks before making an investment decision with respect to the Company’s stock. The following discussion and analysis should be read in conjunction with our financial statements and summary of selected financial data for AMJ Global Technology. Such a discussion represents only the best present assessment from our Management.

Description of Company

AMJ Global Technology (the ‘Company’) was incorporated under the laws of the State of Nevada on August 16, 2013, originally incorporated as Kange Corp. Effective April 22, 2023, the Company filed with the State of Nevada a Certificate of Amendment to its Articles of Incorporation, changing the name of the Company to AMJ Global Technology.

We previously focused on developing mobile software. During 2017, we began focusing on the intersection of technology and wholistic technology-based health treatments. We retained an advisor having substantial experience in the technology sector, and two former professional athletes to advise us regarding sports health issues and treatments. We focused on formulating a treatment model to meet the needs of professional athletes that suffer from PTSD and the early onset of dementia and Alzheimer’s.

On April 26, 2023, the Company entered into an assignment agreement with AMJ Global Entertainment, LLC, a Nevada limited liability company controlled by the Company’s CEO and director, pursuant to which AMJ Global Entertainment assigned to the Company 25% of the ownership rights to AMJ Global Entertainment’s intellectual property in connection with the “Blabeey” platform, including software, code and trade secrets at zero cost.

~~The Company is currently focusing its operations on opportunities in the wholistic health industry.~~ In July of 2024, the Company entered into Revenue Sharing Agreement with Dark Bull Capital, Inc., a Nevada corporation (“Dark Bull”), pursuant to which the Company would issue 133,334 shares of Company common stock to Dark Bull, and the Company would receive 5% of the net revenue generated by Dark Bull from Dark Bull’s contracts with (i) ESS in connection with Medicare enrollees, and (ii) The Agency of North Georgia in connection with Medicare, life and annuity insurance sales. In August of 2024,, the Company entered into a Software Purchase and Development Agreement with Dataark Systems LLC, a Texas LLC (“Dataark”), pursuant to which the Company acquired an 8% interest in Dataark’s ElephantSqlDB® database software in consideration of the issuance of 1,333,333 shares of Company common stock to Dataark. The ElephantSqlDB® database software is designed to leverage AI and quantum computing performance through a specialized architecture and algorithm called the Grover’s Algorithm. The ElephantSqlDB® database is differentiated from its competitors in that is a single database that performs multiple database functions such as supporting 11 SQL dialects in addition to artificial intelligence (AI) data storage, SQL and NoSQL queries. The objective of this technology is to target and cut cloud infrastructure costs significantly while providing immutable security in order to combat evolving threats such as ransomware attacks. On May 7, 2025, the Company entered into an unwinding agreement with the owner of software and technology assets to terminate the agreement dated August 25, 2024. Upon the termination of the original agreement, neither party shall have any further obligations or liabilities under the original agreement, except as expressly provided in the unwinding agreement. The Company received irrevocable cancellation 1,333,333 shares of common stock on May 7, 2025, which were transferred back to the Company as treasury stock.

WeOn ~~have~~July ~~had~~13, ~~limited~~2024, ~~operations~~the ~~and~~Company ~~have~~entered ~~been~~into ~~issued~~ a ~~“going~~Revenue ~~concern”~~Sharing ~~opinion~~agreement bywith ~~our~~a ~~auditor~~company oncontrolled ~~our~~by ~~November~~a 30Target, ~~2023,~~a ~~audited~~related ~~financial~~party ~~statements~~for ~~based~~acquisition ~~upon~~of ~~our~~5% ~~reliance~~of onTarget’s ~~related~~issued ~~party~~and ~~advances~~outstanding ~~and~~stock , pursuant to which the ~~sale~~Company will receive 5% of ~~our~~net ~~common~~revenue ~~stock~~generated asfrom ~~the~~two ~~sole~~contracts ~~source~~with (i) ESS in connection with Medicare enrollees, and (ii) The Agency of ~~funds~~North Georgia in connection with Medicare, life and annuity insurance sales in exchange for ~~our~~133,334 ~~operations~~shares of common stock for ~~the~~a ~~near~~unlimited ~~future~~period.

The following Management Discussion and Analysis should be read in conjunction with the financial statements and accompanying notes included in this Form 10-Q.

Table of Contents

On January 24, 2025, the Company entered into a binding Letter of Intent (LOI) with AMJ Global Entertainment, LLC (“Seller”) , controlled by the Company’s CEO and director for acquisition 100% of AMJ Global Entertainment’s 25% of target’s equity stake in a company controlled by a Target, a related party for amount of $1,000,000 in cash with payment term of two years with an extension of four months to pay the unpaid balance. Should the Company not be able to pay the outstanding balance at the end of twenty- eight (28) months, the Seller has agreed to take any outstanding unpaid balance in the restricted stock of the Company at the price of the stock at the time of signing agreement, which would be $1.00 per share.

On January 27, 2025, the Company entered into a Stock Purchase Agreement with JP Michael LLC, pursuant to which the Company will sell 5,000,000 shares of Company common stock to JP Michael LLC in consideration of 2,000,000 shares of common stock of Diamond Lake Minerals, Inc. As of February 28,2025, the transactions have not been completed. On May 7, 2025, both parties agreed to unwind and terminate the original agreement dated January 27,2025.

We have had limited operations and have been issued a “going concern” opinion by our auditor on our November 30, 2024, audited financial statements based upon our reliance on related party advances and the sale of our common stock as the sole source of funds for our operations for the near future.

The following Management Discussion and Analysis should be read in conjunction with the financial statements and accompanying notes included in this Form 10-Q.

Reports to Security Holders

We intend to furnish our shareholders annual reports containing financial statements audited by our independent registered public accounting firm and to make available quarterly reports containing unaudited financial statements for each of the first three quarters of each year. We voluntarily file Quarterly Reports on Form 10-Q, Annual Reports on Form 10-K and Current Reports on Form 8-K with the Securities and Exchange Commission in order to disclose relevant information regarding the Company. We may also file additional documents with the Commission if they become necessary in the course of our company’s operations.

The public may read and copy any materials that we file with the SEC at the SEC’s Public Reference Room at 100 F Street, NE, Washington, D.C. 20549. The public may obtain information on the operation of the Public Reference Room by calling the SEC at 1-800-SEC-0330. The SEC maintains an Internet site that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC. The address of that site is www.sec.gov.

Results of Operations

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with the condensed financial statements and notes thereto for the period ended ~~August~~February 3128, ~~2024~~2025, which are included herein.

Our operating results for the ~~nine~~three months ended ~~August~~February 3128, ~~2024~~2025, and ~~2023~~February 29, 2024, and the changes between those periods for the respective items are summarized as follows.

For the Three Months Ended ~~August~~February 3128, ~~2024~~2025, and ~~2023~~February 29, 2024

	Three Months Ended
	August 31,				Change
	February 28,		February 29,		Change
	2024		2023		Amount
	2025		2024		Amount
Revenue -related party	$	8	$	-	$	8
Revenue	$	-	$	-	$	-
Operating loss	$	50,~~833~~485	$	1449,~~550~~674	$	~~36,283~~811
Net loss	$	50,825	$	14,550	$	36,275
Other expense		4,877		-		4,877
Net loss	$	55,362	$	49,674	$	5,688

We generated operating revenues-related party of $8 for the three months ended August 31, 2024. The revenue is related to the revenue sharing agreement with Dark Bull, a company controlled by a related party, as described above and pursuant to which the Company acquired 5% of Dark Bull’s net revenue generated from two contracts related to Medicare enrollees, life and annuity insurance.

The Company incurred a net loss of $50,825 during the three months ended August 31, 2024, compared to a net loss of $14,550 for the three months ended August 31, 2023. The increase in net loss was primarily due to an increase in management compensation.

Operating expenses for the three months ended August 31, 2024, and 2023, were $350,833 and $14,550 respectively. For the three months ended August 31, 2024, and 2023, the operating expenses were primarily attributed to management compensation of $35,764 and $0, professional fees of $7,949 and $14,550, and general and administrative expenses of $7,120 and $0, respectively.

For the Nine Months Ended August 31, 2024, and 2023

	Nine Months Ended
	August 31,					Change
	2024			2023		Amount
Revenue	$	8		$	-	$	8
Operating loss	$	145,601		$	790,503	$	(644,902	)
Other income		(98,109	)		-		(98,109	)
Net loss	$	47,484		$	790,503	$	(743,019	)

Table of Contents

WeDuring ~~generated operating revenues-related party of $8 for~~ the ~~nine~~three months ended ~~August~~February 3128, ~~2024.The~~2025, ~~revenue~~and isFebruary ~~related~~29, to2024, ~~the~~we ~~revenue~~did ~~sharing~~not ~~agreement~~have ~~described~~any ~~above~~operating revenues.

The Company incurred a net loss of $4755,~~484~~362 during the ~~nine~~three months ended ~~August~~February 3128, ~~2024~~2025, compared to a net loss of $~~790~~49,~~503~~674 for the ~~nine~~three months ended ~~August~~February 3129, ~~2023~~2024. The ~~decrease~~increase in net loss was primarily due to aan ~~reduction~~ increase in ~~management~~professional ~~compensation~~fees ~~and~~of ~~offset~~$766 byand other ~~income~~expenses ~~for a gain on settlement~~ of ~~debt - related party~~$4,877.

Operating expenses for the ~~nine~~three months ended ~~August~~February 3128, ~~2024~~2025, and ~~2023~~February 29, 2024, were $~~145~~50,~~601~~485 and $~~790~~49,~~503~~674 respectively. For the ~~nine~~three months ended ~~August~~February 3128, ~~2024~~2025, and ~~2023~~February 29,2024, the operating expenses were primarily attributed to management compensation of $9730,~~859~~000 and $~~752~~30,~~380~~000, professional fees of $3718,~~622~~940 and $3618,~~323~~174, and general and administrative expenses of $101,~~120~~545 and $1,~~800~~500, respectively.

Other ~~income~~expenses for the ~~nine~~three months ended ~~August~~February 3128, 2025, and February 29, 2024, ~~was~~were $984,~~109~~877 ~~for~~and a$0 ~~gain~~respectively. onFor ~~settlement~~three months ended February 28, 2025, the other expenses consist of ~~debt~~interest -expenses of $4,726 and amortization expenses of $348 offset by equity investments income-related party of $197.

The equity investments income of $197 is related to 30% equity stake in a company controlled by a related party (“Target”) acquired on July 13, 2024 and January 24, 2025, is accounted for under the equity method as the investment provides the Company with the ability to exercise significant influence over operating and financial policies of Target.

The interest expenses of $4,726 are related to loan payable to a related party in connection with acquisition equity investment dated January 24, 2025, The Company recognized discount on non-interest-bearing loan issued by using Applicable Federal Rate (AFR) of 5.20% for amount of $114,105 for period of loan (twenty-eight months) and recognized interest of $4,726 for three months ended February 28, 2025.

Balance Sheet Data

	August 31,			November 30,			Increase
	February 28,			November 30,			Increase
	2024			2023			(Decrease)
	2025			2024			(Decrease)
Cash	$	~~229~~77		$	-226		$	~~229~~(149	)
Total Assets	$	7889,~~559~~799		$	9,~~140~~253		$	(1880,~~581~~546	)
Total Liabilities	$	~~161~~1,~~021~~133,836		$	~~127~~200,~~215~~928		$	33932,~~806~~908
Working Capital (deficiency)	$	(157,170	)	$	(118,075	)	$	(39,095	)
Working capital (deficiency)	$	(242,858	)	$	(195,422	)	$	(47,436	)

Liquidity and Capital Resources

Based upon our current financial condition, we do not have sufficient cash to operate our business at the current level for the next twelve months. We intend to fund operations through debt and/or equity financing arrangements, which may be insufficient to fund expenditures or other cash requirements. We plan to seek additional financing in a private equity offering to secure funding for operations. There can be no assurance that we will be successful in raising additional funding. If we are not able to secure additional funding, the implementation of our business plan will be impaired. There can be no assurance that such additional financing will be available to us on acceptable terms or at all.

The Company is currently evaluating operations in the wholistic health industry, revenue sharing generated from Medicare enrollees, life and annuity insurance sales, and having 8% right and interest on software, certain additional and related assets belonged to a technology company specializing in the development. This operation will generate revenue and cashflow for the Company. On May 7, 2025, the Company terminated the 8% right and interest on the software and technology assets agreement.

Table of Contents

Working Capital

As of ~~August~~February 3128, ~~2024~~2025, our current assets were $3357,~~851,~~ and our current liabilities were $~~161~~243,~~021~~215, which resulted in working capital deficiency of $~~157~~242,~~170~~858.

As of ~~August~~February 3128, ~~2024~~2025, current assets were comprised of $~~229~~77 in cash, ~~$8 in accounts receivable - related party~~ and $~~3,614~~280 in prepaid expenses, compared to $0226 in cash and $95,~~140~~280 in prepaid expenses as of November 30, ~~2023~~2024. As of ~~August~~February 3128, ~~2024~~2025, current liabilities were comprised of $36,~~393~~869 in accounts payable and accrued liabilities, $~~150~~210,000 in accrued management fees - related party, and $726,~~628~~346 in due to related party, compared to $~~750~~4,762 in accounts payable and accrued liabilities, $~~110~~180,000 in accrued management fees - related party, and $16,~~465~~166 in amounts due to a related party as of November 30, ~~2023~~2024.

Our increase in working capital deficiency is primarily due to an increase in amounts due to a related party and a decrease in cash and prepaid expenses.

6 Table of Contents

Cash Flow Data

	Nine Months Ended
	Three Months Ended
	August 31,
	February 28,			February 29,
	2024			2023
	2025			2024
Cash used in operating activities	$	(3913,~~573~~378	)	$	(3428,~~653~~250	)
Cash provided by financing activities		39,802			34,653
Cash provided by investing activities		49			-
Net change in cash for the period	$	229		$	-
Cash provided by financing activities		13,180			28,250
Net change in cash for the period	$	(149	)	$	-

Cash Flows from Operating Activities

We did not generate positive cash flows from operating activities for the ~~nine~~three months ended ~~August~~February 3128, ~~2024~~2025, and ~~2023~~February 29,2024.

For the ~~nine~~three months ended ~~August~~February 3128, ~~2024~~2025, net cash flows used in operating activities ~~was~~were $3913,~~573~~378, consisting of a net loss of $355,~~917~~362,~~721,~~ increased by equity investments income -related party of $197 and reduced by ~~management~~imputed ~~compensation~~interest of $34,~~878~~726,~~096~~ amortization expenses of $348, accrued management fees - related party of $9030,000, changes in operating assets and liabilities of $87,~~161, and increased by a gain on settlement of debt – related party of $98,109~~107.

For the ~~nine~~three months ended ~~August~~February 3129, ~~2023~~2024, net cash flows used in operating activities was $3428,~~653~~250 consisting of a net loss of $~~790~~49,~~503~~674, reduced by ~~management compensation of $2,380,~~ accrued ~~expenses~~management fees - related party of $~~750~~30,000, and increased by a change in operating assets and liabilities of $38,~~470~~576.

Cash Flows from Investing Activities

For the ~~nine~~three months ended ~~August~~February 3128, ~~2024~~2025, and ~~2023~~February 29, no2024, net cashflows provided by investing activities were ~~used~~$49 inand or$0, ~~provided~~consisting byof ~~investing~~$49 ~~activities~~and $0 distribution from equity investments-related party, respectively.

Cash Flows from Financing Activities

We fund our operations with cash received from advances from officers and related parties and issuances of equity.

~~During~~For the ~~nine~~three months ended ~~August~~February 3128, ~~2024~~2025, and ~~2023~~February 29, 2024, AMJ Global Entertainment LLC, a related party controlled by the Company’s CEO and director, advanced to the Company $3910,~~802~~483 and $3428,~~653~~250, ~~respectively,~~ by paying for operating expenses on behalf of the Company and the Company repaid advances to related party of $303 and $0, respectively.

During the three months ended February 28, 2025, the Company received $3,000 for issuance of 3,000 shares of common restricted stock.

Table of Contents

Critical Accounting Policies

Use of Estimates. The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Concentration

As of August 31, 2024, and for the nine months ended August 31, 2024, customer and revenue concentrations (more than 10%) were 100% related to one revenue sharing agreement with a related party.

7 Table of Contents

Off-Balance Sheet Arrangements

The Company does not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on the Company’s financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to investors.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

As the Company is a “smaller reporting company,” this item is inapplicable.

ITEM 4. CONTROLS AND PROCEDURES.

Disclosure Controls and Procedures

The Securities and Exchange Commission defines the term “disclosure controls and procedures” to mean the company’s controls and other procedures of an issuer that are designed to ensure that information required to be disclosed in the reports that it files or submits under the Securities Exchange Act of 1934 (the “Exchange Act”) is recorded, processed, summarized and reported, within the time periods specified in the Securities and Exchange Commission’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Securities Exchange Act of 1934 is accumulated and communicated to the issuer’s management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. The Company maintains such a simple system of controls and procedures in an effort to ensure that all information which it is required to disclose in the reports it files under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified under the SEC’s rules and forms and that information required to be disclosed is accumulated and communicated to principal executive and principal financial officers to allow timely decisions regarding disclosure.

As of the end of the period covered by this report, we carried out an evaluation, under the supervision and with the participation of our chief executive officer and chief financial officer, of the effectiveness of the design and operation of our disclosure controls and procedures. Based on this evaluation, our chief executive officer and chief financial officer concluded that our disclosure controls and procedures were not effective to provide reasonable assurance of achieving the objectives of timely alerting them to material information required to be included in our periodic SEC reports and of ensuring that such information is recorded, processed, summarized and reported with the time periods specified. Our chief executive officer and chief financial officer also concluded that our disclosure controls and procedures were not effective as of the end of the period covered by this report to provide reasonable assurance of the achievement of these objectives.

Changes in Internal Control over Financial Reporting

There were no changes in the Company’s internal control over financial reporting identified in connection with the evaluation required by paragraph (d) of Rule 13a-15 or 15d-15 of the Exchange Act that occurred during the quarter ended ~~August~~February 3128, ~~2024~~2025, that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

On March 5, 2025, the notified Green Growth, CPA of its dismissal as the Company’s independent registered public accounting firm. On March 5, 2025, the Company engaged Barton CPA PLLC of Cypress, Texas as the Company’s independent registered public accounting firm.

Table of Contents

PART II - OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS.

The Company is not a party to any significant pending legal proceedings other than as disclosed below, and no other such proceedings are known to be contemplated. No director, officer or affiliate of the Company, and no owner of record or beneficial owner of more than 5.0% of the securities of the Company, or any associate of any such director, officer or security holder is a party adverse to the Company or has a material interest adverse to the Company in reference to pending litigation.

ITEM 1A. RISK FACTORS.

Not applicable.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

~~None~~During the three months ended February 28, 2025, the Company issued 3,000 shares of common stock for contribution of $3,000 in cash.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES.

~~During the period ended May 31, 2024, the Company issued 1,002,200 shares of common stock for settlement of debts, compensation-related party, and services-related party, as follows:~~ None.

On July 10, 2024, the Company issued 133,334 shares of common stock to Dark Bull, a company controlled by a related party, pursuant to the revenue sharing agreement described above, valued at $337.

On August 6, 2024, the Company issued 2,000,000 shares of common stock to the Company’s CEO, Dr. Arther Malone, Jr., as compensation, valued at $5,056.

On August 6, 2024, the Company issued 100,000 shares of common stock to Robert Stutman, a member of the Company’s Board of Directors, as compensation, valued at $253.

On August 6, 2024, the Company issued 50,000 shares of common stock to Jesse Anglen, a member of the Company’s Board of Directors, as compensation, valued at $126.

On August 6, 2024, the Company issued 50,000 shares of common stock to Adrian Neilan, a member of the Company’s Board of Directors, as compensation, valued at $126.

On August 6, 2024, the Company issued 50,000 shares of common stock to Jesse Vern Barkdull, a member of the Company’s Board of Directors, as compensation, valued at $126.

On August 6, 2024, the Company issued 30,000 shares of common stock to Alan Klitenic in consideration of his appointment as a member of the Company’s Board of Advisors, valued at $76.

On August 26, 2024, the Company issued 1,333,333 shares of common stock to Dataark for the acquisition of 8% of the database software and related technology assets described above, valued at $3,371.

The above-described shares were issued pursuant to the exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933, as amended, and Rule 506(b) promulgated thereunder, as there was no general solicitation, the shareholders were accredited and/or financially sophisticated, and the transactions did not involve a public offering.

ITEM 4. MINE SAFETY DISCLOSURES.

None.

ITEM 5. OTHER INFORMATION.

None.

Table of Contents

ITEM 6. EXHIBITS.

Exhibit		Description
3.1		Articles of Incorporation (incorporated by reference to our Registration Statement on Form S-1, filed on February 21, 2014)
3.2		Bylaws (incorporated by reference to our Registration Statement on Form S-1, filed on February 21, 2014)
3.3		Bylaws (incorporated by reference to our Registration Statement on Form S-1, filed on February 21, 2014)
10.1		Assignment of Rights Agreement between the Company and AMJ Global (incorporated by reference to our Current Report on Form 8-K filed on November 12, 2015)
10.2		Board Member Agreement, by and between the Company and Robert Stutman, dated March 26, 2024 (incorporated by reference to Exhibit 10.1 to our Current Report on Form 8-K filed on April 1, 2024)
10.3		Board Member Agreement, by and between the Company and Adrian Neilan, dated March 26, 2024 (incorporated by reference to Exhibit 10.2 to our Current Report on Form 8-K filed on April 1, 2024)
10.4		Board Member Agreement, by and between the Company and Jesse Anglen, dated March 26, 2024 (incorporated by reference to Exhibit 10.3 to our Current Report on Form 8-K filed on April 1, 2024)
10.5		Board Member Agreement, by and between the Company and Vern Barkdull, dated March 26, 2024 (incorporated by reference to Exhibit 10.4 to our Current Report on Form 8-K filed on April 1, 2024)
10.6		Revenue Sharing Agreement, by and between the Company and Dark Bull, dated July 13, 2024 (incorporated by reference to Exhibit 10.1 to our Current Report on Form 8-K filed on July 18, 2024)
10.7		Software Purchase and Development Agreement between AMJ Global Technology and Dataark Systems LLC, dated August 25, 2024 (incorporated by reference to Exhibit 10.1 to our Current Report on Form 8-K filed on August 27, 2024)
10.8		Purchase Agreement, by and between the Company and AMJ Global Entertainment LLC, dated January 24, 2025 (incorporated by reference to Exhibit 10.1 to our Current Report on Form 8-K filed on January 27, 2025)
10.9		Stock Purchase Agreement, by and between the Company and JP Michael LLC, dated January 27, 2025 (incorporated by reference to Exhibit 10.1 to our Current Report on Form 8-K filed on January 28, 2025)
31.1/31.2*		Certification of Chief Executive Officer and Chief Executive Financial Officer required by Rule 13a-14(1) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1/32.2*		Certification of Chief Executive Officer and Chief Executive Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and Section 1350 of 18 U.S.C. 63
101*		Inline XBRL Document Set for the condensed financial statements and accompanying notes in Part I, Item 1, “Financial Statements” of this Quarterly Report on Form 10-Q.
104*		Inline XBRL for the cover page of this Quarterly Report on Form 10-Q, included in the Exhibit 101 Inline XBRL Document Set.

____________

* Filed herewith.

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	AMJ Global Technology
Date: October 23, 2024	By:	/s/ Dr. Arthur Malone, Jr.
Date: May 28, 2025	By:	/s/ Dr. Arthur Malone, Jr.
		Dr. Arthur Malone, Jr.
		Chief Executive Officer,Chief Financial Officer and Director

Filing Compare · AMJ Global Technology